Protalix BioTherapeutics Inc (PLX)
1.69
+0.03
(+1.81%)
USD |
NYAM |
Nov 22, 16:00
1.70
+0.01
(+0.59%)
After-Hours: 20:00
Protalix BioTherapeutics Cash from Operations (Quarterly): 4.105M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.105M |
| June 30, 2024 | -3.61M |
| March 31, 2024 | 4.188M |
| December 31, 2023 | 3.595M |
| September 30, 2023 | -6.888M |
| June 30, 2023 | 4.973M |
| March 31, 2023 | -2.998M |
| December 31, 2022 | -2.611M |
| September 30, 2022 | -9.204M |
| June 30, 2022 | -7.356M |
| March 31, 2022 | -5.829M |
| December 31, 2021 | -5.087M |
| September 30, 2021 | -1.88M |
| June 30, 2021 | 6.516M |
| March 31, 2021 | -9.834M |
| December 31, 2020 | -7.55M |
| September 30, 2020 | -3.604M |
| June 30, 2020 | -7.835M |
| March 31, 2020 | -7.117M |
| December 31, 2019 | -3.687M |
| September 30, 2019 | -3.225M |
| June 30, 2019 | -5.17M |
| March 31, 2019 | -7.276M |
| December 31, 2018 | -4.004M |
| September 30, 2018 | 13.64M |
| Date | Value |
|---|---|
| June 30, 2018 | -7.964M |
| March 31, 2018 | -9.413M |
| December 31, 2017 | 17.59M |
| September 30, 2017 | -10.54M |
| June 30, 2017 | -8.619M |
| March 31, 2017 | -8.426M |
| December 31, 2016 | -7.338M |
| September 30, 2016 | -3.443M |
| June 30, 2016 | -11.69M |
| March 31, 2016 | -9.625M |
| December 31, 2015 | -3.857M |
| September 30, 2015 | -8.66M |
| June 30, 2015 | -5.346M |
| March 31, 2015 | -6.421M |
| December 31, 2014 | -4.874M |
| September 30, 2014 | -9.548M |
| June 30, 2014 | -6.519M |
| March 31, 2014 | -8.34M |
| December 31, 2013 | -4.742M |
| September 30, 2013 | -8.216M |
| June 30, 2013 | -8.109M |
| March 31, 2013 | -9.586M |
| December 31, 2012 | 1.821M |
| September 30, 2012 | -8.029M |
| June 30, 2012 | 13.12M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-9.834M
Minimum
Mar 2021
6.516M
Maximum
Jun 2021
-3.086M
Average
-3.648M
Median
Cash from Operations (Quarterly) Benchmarks
| Accuray Inc | -7.294M |
| Aethlon Medical Inc | -2.215M |
| AIM ImmunoTech Inc | -3.11M |
| Perspective Therapeutics Inc | 3.366M |
| Armata Pharmaceuticals Inc | -8.863M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 20.33M |
| Cash from Financing (Quarterly) | -20.42M |
| Free Cash Flow | 7.171M |
| Free Cash Flow Per Share (Quarterly) | 0.0495 |
| Free Cash Flow to Equity (Quarterly) | 24.44M |
| Free Cash Flow to Firm (Quarterly) | 4.143M |
| Free Cash Flow Yield | 5.40% |